Mali Med
November 2024
Objective: The aim of this study was to investigate adverse events related to the administration of Covishield vaccine from the AstraZeneca laboratory in volunteers vaccinated at the Dermatology Hospital of Bamako.
Methodology: This was a Phase IV clinical trial involving volunteers vaccinated at the Dermatology Hospital of Bamako from April to June 2021. Scientific and ethical aspects were reviewed and addressed.
Aim: To assess the COVID-19 patients' treatment duration according to the place of treatment at the Dermatology Hospital of Bamako (DHB).
Methods: This was a cross-sectional study comparing the management of COVID-19 PCR-positive patients in the hospital to that of those managed at home from March 2020 to April 2021 until two consecutive negative PCR 48 hours apart.
Results: Among the 1109 patients, 369 were hospitalized, 497 followed at home.
Introduction: The association between HIV and cancer is becoming more and more frequent, given the increased life expectancy of HIV positive patients with triple antiretroviral therapy. This association had not been documented in our service, hence the aim of this work. Our objectives were to describe the epidemiological and clinical characteristics and to determine outcome of patients with both pathologies.
View Article and Find Full Text PDFPurpose: Cerebral malaria (CM) is suspected to be a potential cause of epilepsy in tropical areas, but little information is available. The purpose of this study was to evaluate the role of CM in epilepsy among children in Mali.
Methods: An exposed-nonexposed study was performed to identify children who had epilepsy after malaria in the 0- to 15-year age group.